Division

Anatomic Pathology  

Certifications

Anatomic Pathology   

Memberships

Alpha Omega Alpha
American Association for the Advancement of Science
Association for Molecular Pathology

Departmental Affiliations

Pathology  

Publications

1. Kudva, G.C., Maliekel, K., Richart, J.M., Batanian, J.R., Grosso, L.E., Sokol-Anderson, M., Petruska, P.J. Acute Promyelocytic Leukemia and HIV-1 Infection: Case Report and Review of the Literature. American Journal of Hematology 77:287-289, 2004.

2. Frater, J.L., Batanian, J.R., O’Connor, D.M., Grosso, L.E. Lymphoblastic Leukemia with Mature B-cell Phenotype. Journal of Pediatric Hematology/Oncology 26:672-677 (2004).

3. Voora, D., Eby,C., Linder, M., Milligan, P.E., Bukaveckas, P.L., McLeod, H.L., Maloney, W., Clohisy, J., Burnett, R.S., Grosso, L.E., Gatchel, S.K., Gage, B.F. Prospective Dosing of Warfarin Based on Cytochrom P-450 2C9 Genotype. Thromb Haemost. 93(4):700-5 (2005).

4. Basu, A., Meyer, K., Lai, K.K., Saito, K., Di Bisceglie, A.M., Grosso, L.E., Ray, R.B., Ray, R. Microarray Analyses and Molecular Profiling of Stat3 Signaling Pathway Induced by Hepatitis C Virus Core Protein in Human Hepatocytes. Virology 349:347-358 (2006).

5. Frater, JL, Kling, CW, Obadiah, JM, Gardner, LJ, Grosso, LE, Resh, B, Hurley, MY. Histiocytic Sarcoma with Secondary Involvement of the Skin and Expression of CD1a: Evidence of Indeterminate Cell Differentiation. J Cutan Pathology 33:437-42 (2006).

6. Variability of ZAP 70 Expression in a Patient with CLL (Letter). Charr, BT, Petruska, PJ. Grosso, L. Am J Hematol. 81: 645 (2006).

7. Discordance of ZAP-70 in Patients with Chronic Lymphocytic Leukemia. Chaar, BT, Shergen, AK, Grosso LE. International Journal of Laboratory Haematology 30:36-40 (2008).

8. Genetic-Based Dosing in Orthopedic Patients Beginning Warfarin Therapy. Millican E, Jacobsen PA, Milligan PE, Grosso LE, Eby C, Deych E, Grice G, Clohisy JC, Barrack RL, R. Burnett SJ, Voora D, Gatchel S, Tiemeier A, Howard M., Gage BF. Blood 2007 110:1511-1515.

9. Use of Pharmacogenetics and Clinical Factors to Predict the Therapeutic Dose of Warfarin. Gage BF, Eby C, Johnson JA, Deych E, Rieder MJ, Ridker PM, Milligan PE, Grice G., Lenzini P, Rettie AE, Aquilante CL, Grosso L, Marsh S, Langaee T, Farnett LE, Voora DI, Veenstra DL, Glynn R, Barrett A, McLeod HL Clinical Pharmacololgy and Therapeutics 84(3):326-331 (2008).

10. Surgery for Nasal NK/T-Cell Lymphomas. Nahir R, Grosso L, Judva G. Leukemia Lymphoma 49(11):2206-2208 (2008).

PUBMED

Modified Date:Monday 23-Jul-12 16:38:03 CDT